E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial
More details
Hide details
National Institute for Health Innovation, School of Population Health, The University of Auckland, Auckland, New Zealand
Natalie Walker   

National Institute for Health Innovation, School of Population Health, The University of Auckland, Auckland, New Zealand
Publish date: 2015-03-24
Tobacco Induced Diseases 2015;13(March):5
People with mental illness have higher rates of smoking than the general population and are at greater risk of smoking-related death and disability. In smokers from the general population, electronic cigarettes (e-cigarettes) have been shown to have a similar effect on quit rates as nicotine replacement therapy, but little is known about their effect in smokers with mental illness.

Secondary analysis of data from the ASCEND trial involving 657 dependent adult smokers motivated to quit, randomised to 16 mg nicotine e-cigarette, 21 mg nicotine patch, or 0 mg nicotine e-cigarette, with minimal behavioural support. Using self-reported medication use and the Anatomical Therapeutic Chemical Classification System, we identified 86 participants with mental illness and analysed their cessation and smoking reduction outcomes.

For e-cigarettes alone, and all interventions pooled, there was no statistically significant difference in biochemically verified quit rates at six months between participants with and without mental illness, nor in smoking reduction, adverse events, treatment compliance, or acceptability. Rates of relapse to smoking were higher in participants with mental illness. Among this group, differences between treatments were not statistically significant for cessation (patch 14% [5/35], 16 mg e-cigarette 5% [2/39], 0 mg e-cigarette 0% [0/12], p = 0.245), adverse events or relapse rates. However, e-cigarette users had higher levels of smoking reduction, treatment compliance, and acceptability.

The use of e-cigarettes for quitting appears to be equally effective, safe, and acceptable for people with and without mental illness. For people with mental illness, e-cigarettes may be as effective and safe as patches, yet more acceptable, and associated with greater smoking reduction.

1. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212–7.
2. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction. 2010;105(7):1176–89.
3. Campion J, Checinski K, Nurse J, McNeill A. Smoking by people with mental illness and benefits of smoke-free mental health services. Adv Psychiatr Treat. 2008;14:217–28.
4. Smith PH, Homish GG, Giovino GA, Kozlowski LT. Cigarette smoking and mental illness: a study of nicotine withdrawal. Am J Public Health. 2014;104(2):e127–33. doi:10.2105/ajph.2013.301502.
5. Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the US population. Tob Control. 2014;23(e2):e147–53. doi:10.1136/tobaccocontrol-2013-051466.
6. Callaghan RC, Veldhuizen S, Jeysingh T, Orlan C, Graham C, Kakouris G, et al. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J Psychiatr Res. 2014;48(1):102–10.
7. Centers for Disease Control and Prevention. Vital signs: Current cigarette smoking among adults aged aged ≥ 18 Years—United States, 2009–2011. MMWR Morb Mortal Wkly Rep. 2013;62(5):81–7.
8. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15:357–76.
9. McManus S, Meltzer H, Brugha T, Bebbington P, Jenkins R. Adult Psychiatric Morbidity Survey 2007. Results of a household survey. The NHS Health & Social Care Information Centre, Social Care Statistics; 2009.
10. McCreadie R, Kelly C. Patients with schizophrenia who smoke. Private disaster, public resource. Br J Psychiatry. 2000;176:109.
11. Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction. 2009;104(5):719–33.
12. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013;2:CD007253. doi:10.1002/14651858.CD007253.pub3.
13. Pachas G, Cather C, Pratt S, Hoeppner B, Nino J, Carlini S, et al. Varenicline for smoking cessation in schizophrenia: safety and effectiveness in a 12-week, open-label trial. J Dual Diagn. 2012;8(2):1178–125.
14. Rüther T, Bobes J, De Hert M, Svensson TH, Mann K, Batra A, et al. EPA Guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry. 2014;29(2):65–82.
15. van der Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev. 2013;8:CD006102. doi:10.1002/14651858.CD006102.pub2.
16. Kishi T, Iwata N. Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014. doi:10.1007/s00406-014-0551-3.
17. Parker C, McNeill A, Ratschen E. Tailored tobacco dependence support for mental health patients: a model for inpatient and community services. Addiction. 2012;107 Suppl 2:18–25.
18. Royal College of Physicians. Smoking and Mental Health. London: RCP; 2013.
19. Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA. 2014;311(2):172–82. doi:10.1001/jama.2013.284985.
20. Caponnetto P, Campagna D, Cibella F, Morjaria J, Caruso M, Russo C, et al. Efficiency and Safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317. doi:10.1371/journal.pone.0066317.
21. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629–37.
22. Adriaens K, Van Gucht D, Declerck P, Baeyens F. Effectiveness of the electronic cigarette: an eight-week flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health. 2014;11(11):11220–48. doi:10.3390/ijerph111111220.23.
23. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health. 2013;10(2):446–61.
24. Caponnetto P, Polosa R, Russo C, Leotta C, Campagna D. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Rep. 2011;5:585.
25. Caponnetto P, Polosa R, Auditore R, Russo C, Campagna D. Smoking cessation with e-cigarettes in smokers with a documented history of depression and recurring relapses. Int J Clin Med. 2011;2:281–4.
26. Schneiderhan M. A case report of patient-initiated e-cigarette use and resulting 5-months smoking cessation. J Pharm Pract. 2012;25(2):297.
27. Cummins SE, Zhu S-H, Tedeschi GJ, Gamst AC, Myers MG. Use of e-cigarettes by individuals with mental health conditions. Tob Control. 2014;23 suppl 3:iii48–53. doi:10.1136/tobaccocontrol-2013-051511.
28. Prochaska JJ, Grana RA. E-Cigarette Use among Smokers with Serious Mental Illness. PLoS One. 2014;9(11):e113013.
29. Bullen C, Williman J, Howe C, Laugesen M, McRobbie H, Parag V, et al. Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation. BMC Public Health. 2013;13:210. doi:10.1186/471-2458-13-210.
30. WHO Collaborating Centre for Drug Statistics Methodology. ATC structure and principles. 2011. [cited 2013 29/11/13]; Available from:
31. Heatherton T, Kozlowski L, Frecker R, Fagerstrom K. The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119–27.
32. Glover ED, Nilsson F, Westin A, Glover PN, Laflin MT, Persson B. Developmental history of the Glover-Nilsson smoking behavioral questionnaire. Am J Health Behav. 2005;29(5):443–55. doi:10.5555/ajhb.2005.29.5.443.
33. DiFranza JR, Wellman RJ, Ursprung WW, Sabiston C. The autonomy over smoking scale. Psychol Addict Behav. 2009;23(4):656–65. doi:10.1037/a0017439.
34. Hajek P. Electronic cigarettes for smoking cessation. Lancet. 2013.
35. NICE. National Institute for Health and Clinical Excellence (NICE). Tobacco: harm-reduction approaches to smoking. PH45. 2013 01-Dec-2014; Available from:
36. Wilson N, Weerasekera D, Collings S, Edwards R, Deen FS. Poorer mental health in many New Zealand smokers: national survey data from the ITC Project. N Z Med J. 2010;123(1326):129–32.
1. Australian mental health care practitioners’ practices and attitudes for encouraging smoking cessation and tobacco harm reduction in smokers with severe mental illness
Ratika Sharma, Carla Meurk, Stephanie Bell, Pauline Ford, Coral Gartner
International Journal of Mental Health Nursing
2. The challenge of reducing smoking in people with serious mental illness
Ratika Sharma, Coral E Gartner, Wayne D Hall
The Lancet Respiratory Medicine
3. Electronic cigarettes and mental illness: Reviewing the evidence for help and harm among those with psychiatric and substance use disorders
Kathryn Hefner, Gerald Valentine, Mehmet Sofuoglu
The American Journal on Addictions
4. Electronic nicotine devices considered through an equity lens
Billie Bonevski, Ashleigh Guillaumier, Laura Twyman
5. Electronic Cigarettes for Smoking Cessation: A Systematic Review
Muhannad Malas, Jan van der Tempel, Robert Schwartz, Alexa Minichiello, Clayton Lightfoot, Aliya Noormohamed, Jaklyn Andrews, Laurie Zawertailo, Roberta Ferrence
Nicotine & Tobacco Research
6. Use of Electronic Nicotine Delivery Systems among Adults with Mental Health Conditions, 2015
Claire Spears, Dina Jones, Scott Weaver, Terry Pechacek, Michael Eriksen
International Journal of Environmental Research and Public Health
7. Improving life expectancy in people with serious mental illness: Should we place more emphasis on primary prevention?
Athif Ilyas, Edward Chesney, Rashmi Patel
British Journal of Psychiatry
8. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis
Sara Kalkhoran, Stanton A Glantz
The Lancet Respiratory Medicine
9. Efficacité et sécurité de la cigarette électronique pour la réduction du tabagisme : revue systématique et méta-analyse
Paul Vanderkam, Rémy Boussageon, Michel Underner, Nicolas Langbourg, Yann Brabant, Philippe Binder, Bernard Freche, Nematollah Jaafari
La Presse Médicale
10. An appraisal of practice guidelines for smoking cessation in people with severe mental illness
Ratika Sharma, Kristel Alla, Daniel Pfeffer, Carla Meurk, Pauline Ford, Steve Kisely, Coral Gartner
Australian & New Zealand Journal of Psychiatry
11. How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor
Andrea C. Villanti, Shari P. Feirman, Raymond S. Niaura, Jennifer L. Pearson, Allison M. Glasser, Lauren K. Collins, David B. Abrams
12. Overview of Electronic Nicotine Delivery Systems: A Systematic Review
Allison M. Glasser, Lauren Collins, Jennifer L. Pearson, Haneen Abudayyeh, Raymond S. Niaura, David B. Abrams, Andrea C. Villanti
American Journal of Preventive Medicine
13. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products
David T. Levy, K. Michael Cummings, Andrea C. Villanti, Ray Niaura, David B. Abrams, Geoffrey T. Fong, Ron Borland
14. Views and Preferences for Nicotine Products as an Alternative to Smoking: A Focus Group Study of People Living with Mental Disorders
Carla Meurk, Pauline Ford, Ratika Sharma, Lisa Fitzgerald, Coral Gartner
International Journal of Environmental Research and Public Health
15. Motivations and Limitations Associated with Vaping among People with Mental Illness: A Qualitative Analysis of Reddit Discussions
Ratika Sharma, Britta Wigginton, Carla Meurk, Pauline Ford, Coral Gartner
International Journal of Environmental Research and Public Health
16. Rates of electronic cigarette use among adults with a chronic mental illness
Cynthia L. Bianco
Addictive Behaviors
17. Weighing the Risks and Benefits of Electronic Cigarette Use in High-Risk Populations
Deepa R. Camenga, Hilary A. Tindle
Medical Clinics of North America
18. Are Australian smokers with mental illness receiving adequate smoking cessation and harm reduction information?
Ratika Sharma-Kumar, Carla Meurk, Pauline Ford, Diana Beere, Coral Gartner
International Journal of Mental Health Nursing
19. Electronic nicotine devices to aid smoking cessation by alcohol- and drug-dependent clients: protocol for a pilot randomised controlled trial
Ashleigh Guillaumier, Victoria Manning, Olivia Wynne, Coral Gartner, Ron Borland, Amanda L. Baker, Catherine J. Segan, Eliza Skelton, Lyndell Moore, Ramez Bathish, Dan I. Lubman, Billie Bonevski
20. Are Electronic Cigarettes an Effective Aid to Smoking Cessation or Reduction Among Vulnerable Groups? A Systematic Review of Quantitative and Qualitative Evidence
Sarah Gentry, Nita G Forouhi, Caitlin Notley
Nicotine & Tobacco Research
21. Do Electronic Cigarettes Have a Role in Tobacco Cessation?
Andrea S. Franks, Karen Sando, Sarah McBane
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
22. Managing nicotine without smoke to save lives now: Evidence for harm minimization
David B. Abrams, Allison M. Glasser, Andrea C. Villanti, Jennifer L. Pearson, Shyanika Rose, Raymond S. Niaura
Preventive Medicine
23. The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial
Chris Bullen, Marjolein Verbiest, Susanna Galea-Singer, Tomasz Kurdziel, George Laking, David Newcombe, Varsha Parag, Natalie Walker
BMC Public Health